Free After more than a decade, ASCO sells CancerLinQ to ConcertAI December 11, 2023Vol.49 No.46By Paul Goldberg
Conversation with The Cancer LetterFree Hudis: ASCO had the vision, but was low on resources CancerLinQ required December 11, 2023Vol.49 No.46By Paul Goldberg
FreeObituary Worta McCaskill-Stevens understood the importance of explaining cancer prevention December 01, 2023Vol.49 No.44By Otis W. Brawley and Lucile L. Adams-Campbell
FreeObituary Worta McCaskill-Stevens, MD: An appreciation for a driving force in cancer prevention and addressing cancer disparities December 01, 2023Vol.49 No.44By Division of Cancer Prevention staff
FreeObituary Michelle Rudek, director of Analytical Pharmacology Shared Resource at Hopkins, dies at 51 November 17, 2023Vol.49 No.43By Johns Hopkins Kimmel Cancer Center staff
Conversation with The Cancer LetterFree John Carpten: City of Hope’s national strategy drew me to this opportunity November 10, 2023Vol.49 No.42By Paul Goldberg
FreeLetter To The Editor Mohammed Dabbour, cancer pathologist, killed in Gaza November 10, 2023Vol.49 No.42By Abdelghani Tbakhi
FreeIn the Archives How George Santos and Al Owens’s early Cytoxan studies led to standard-of-care therapy in BMT November 10, 2023Vol.49 No.42By Alexandria Carolan
